In Dispute: Amylin | Practical Law
This document discusses the dispute surrounding the proxy contest between Amylin Pharmaceuticals, Inc. and its stockholders, Icahn Capital LP and affiliated funds and Eastbourne Capital Management, L.L.C., and provides a summary of key litigated issues and practical implications indicated by the litigation.